The Treatment of Chronic Depression, Part 3

作者：Ivan W. Miller, Gabor I. Keitner, Alan F. Schatzberg, Daniel N. Klein, Michael E. Thase, Augustus John Rush, John C. Markowitz, David S. Schlager, Susan G. Kornstein, Sonia M. Davis, Wilma M. Harrison, Martin B. Keller · 发表于：The Journal of Clinical Psychiatry · 年份：1998 · DOI：10.4088/jcp.v59n1108 · 被引用次数：306 · 研究领域：Treatment of Major Depression、Mental Health Treatment and Access、Digital Mental Health Interventions

BACKGROUND: Previous research has suggested that depressed patients, and particularly chronically depressed patients, have significant impairments in many areas of their lives. While previous studies suggested that these "psychosocial" impairments improve following pharmacologic treatment, no large scale definitive study using multiple measures of psychosocial functioning has been reported. METHOD: We assessed multiple domains of psychosocial functioning using interviewer-rated and self-report measures within the context of a 12-week acute treatment trial of sertraline and imipramine for patients with chronic depression (double depression and chronic major depression). We also compared the psychosocial functioning data of this sample before and after treatment with normative data available from published community samples. RESULTS: Chronically depressed patients manifested severe impairments in psychosocial functioning at baseline. After treatment with sertraline or imipramine, psychosocial functioning improved significantly. Significant improvements appeared relatively early in treatment (week 4). Despite these highly significant improvements in functioning during acute treatment, the study sample as a whole did not achieve levels of psychosocial functioning comparable to a comparator nondepressed community sample. However, patients who reached full symptomatic response (remission) during acute treatment did have levels of psychosocial functioning in most areas at endpoint t...